SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Hauser W, Hesdorffer D. Epilepsy: frequency, causes and consequences. New York : Demos Medical Publishing, 1990: 93118.
  • 2
    Jallon P. Epilepsy in developing countries. Epilepsia 1997;38: 114351.
  • 3
    Shorvon S. Epidemiology, classification, natural history, and genetics of epilepsy. Lancet 1990;336: 936.DOI: 10.1016/0140-6736(90)91603-8
  • 4
    Gracia F. Epidemiología de las epilepsias en Latinoamerica. In: MedinaMT, ChávezF, Chinchilla Net al., eds. Las epilepsias en centroamérica. Tegucigalpa : Scancolor, 2001: 1722.
  • 5
    Senanayake N, Román G. Epidemiology of epilepsy in developing countries. Bull WHO 1993;71: 24758.
  • 6
    Annegers JF. The epidemiology of epilepsy. In: WyllieE, ed. The treatment of epilepsy: principles and practices. 2nd ed. Baltimore : Williams & Wilkins, 1996: 16572.
  • 7
    Sander J, Shorvon S. Incidence and prevalence studies in epilepsy and their methodological problems: a review. J Neurol Neurosurg Psychiatry 1987;50: 82939.
  • 8
    Commission on Epidemiology and Prognosis of the International League Against Epilepsy. Guidelines for epidemiological studies on epilepsy. Epilepsia 1993;34: 5926.
  • 9
    Annegers JF, Rocca WA, Hauser WA. Causes of epilepsy: contributions of the Rochester epidemiology project. Mayo Clin Proc 1996;71: 5705.
  • 10
    Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised clinical and electrographic classification of epileptic seizures. Epilepsia 1981;22: 489501.
  • 11
    Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30: 38999.
  • 12
    Engel J. A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 2001;42: 18.
  • 13
    Martínez L, Banegas L, Cartagena D. Análisis de situación de salud según condiciones de vida (ASIS/SCV), Municipios del Norte de Olancho 2002: reporte a la Secretaria de Salud, Julio 2002.
  • 14
    Medina MT, Durón R, Ramírez F, et al. Prevalence of neurological disorders in Tegucigalpa: the Kennedy Study. Rev Med Hond 2003;71: 817.
  • 15
    Varela F, Nicolás O, Durón R, et al. Aspectos antropológicos y culturales que inciden en la determinación de la prevalencia de las epilepsias en la etnia miskita de Honduras. Rev Med Hond 2002;70: 914
  • 16
    Sánchez AL, Lindback J, Schantz PM, et al. A population based, case-control study of Taenia solium taeniasis and cysticercosis. Ann Trop Med Parasitol 1999;93: 24758.
  • 17
    Aziz H, Ali SM, Frances P, et al. Epilepsy in Pakistan: a population-based epidemiologic study. Epilepsia 1994;35: 9508.
  • 18
    Placencia M, Sander JWAS, Shorvon SD, et al. Validation of a screening questionnaire for the detection of epileptic seizures in epidemiological studies. Brain 1992;115: 78394.
  • 19
    Pradilla G, Vesga VE, Leon-Sarmiento FE, et al. Neuroepidemiologia en el oriente colombiano. Rev Neurol 2002;34: 103543.
  • 20
    Nicoletti A, Regio A, Bartoloni A, et al. Prevalence of epilepsy in rural Bolivia: A door-to-door survey. Neurology 1999;53: 20649.
  • 21
    Wang WZ, Wu JZ, Wang DS, et al. The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study. Neurology 2003;60: 15445.
  • 22
    Medina MT, Molina L, Durón R, et al. Prevalence of the epilepsies in Honduras: a national population-based study. Epilepsia 2003;44: 155.
  • 23
    Sánchez AL, Durón R, Osorio J, et al. Evaluation of the enzyme-linked immunoelectrotransfer blot (EITB) assay in epileptic patients from a rural community in Honduras. Proc IX Intl Congr Parasitol ICOPA 1998;9: 1859.
  • 24
    Sánchez AL, Ljungström I, Medina MT. Diagnosis of human neurocysticercosis in endemic countries: a clinical study in Honduras. Parasitol Int 1999;48: 819.
  • 25
    Del Brutto OH, Rajshekhar V, White AC, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001;57: 17783.
  • 26
    Roger J, Genton P, Bureau M. La classification internationale des epilepsies et des syndromes épileptiques adopteé au Congrèss de New Delhi (Octobre 1989): commentaries et traduction. Epilepsies 1990;2: 18397.
  • 27
    Kale R. Global campaign against epilepsy: the treatment gap. Epilepsia 2002;43: 313.
  • 28
    Hauser WA, Kurland LT. Epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967. Epilepsia 1975;16: 166.
  • 29
    Granieri E, Rosati G, Tola R, et al. A descriptive study of epilepsy in the district of Copparo, Italy, 1964–1978. Epilepsia 1983;24: 50214.
  • 30
    Zuloaga L, Soto C, Jaramillo D. Prevalencia de epilepsia en Medellín. Bol Sanit Panama 1988;104: 33144.
  • 31
    Gracia FJ, Bayard V, Triana E, et al. Prevalencia de enfermedades neurológicas en el Corregimiento Belisario Porras Distrito de San Miguelito, Panamá, 1986. Rev Med Panama 1988;13: 405.
  • 32
    Gracia F, De Lao SL, Castillo L, et al. Epidemiology of epilepsy in Guaymi Indians from Bocas del Toro Province, Republic of Panama. Epilepsia 1990;31: 71823.
  • 33
    Osuntokun BO, Adeuja AOG, Nottidge VA, et al. Prevalence of the epilepsies in Nigerian Africans: a community-based study. Epilepsia 1987;28: 2729.
  • 34
    Annegers J, Hauser W, Lee J, et al. Incidence of acute symptomatic seizures in Rochester, Minnesota 1935–1984. Epilepsia 1995;36: 32733.
  • 35
    Scher MS. Seizures in special clinical settings: neonatal seizures. In: WyllieE, ed. The treatment of epilepsy: principles and practices. 2nd ed. Baltimore : Williams & Wilkins, 1996: 60021.
  • 36
    Sander J, Hart Y, Johnson A, et al. National General Practice Study of Epilepsy: newly diagnosed epileptic seizures in a general population. Lancet 1990;336: 126771.
  • 37
    Jack C Jr. Magnetic resonance imaging in epilepsy. Mayo Clin Proc 1996;71: 695711.
  • 38
    Connor SE, Jarosz JM. Magnetic resonance imaging of patients with epilepsy. Clin Radiol 2001;56: 787801.
  • 39
    Medina MT. Epilepsy due to neurocysticercosis. Neurology 1992;42: 2055.
  • 40
    Nash TE, Del Brutto OH, Butman JA, et al. Calcific neurocysticercosis and epileptogenesis. Neurology 2004;62: 19348.
  • 41
    Medina MT, DeGiorgio C. Introduction to neurocysticercosis: a worldwide epidemic. Neurosurg Focus 2002;12: 6.
  • 42
    Trevathan E, Medina MT, Madrid A. A broad-spectrum anti-epileptic drug for the developing world. Lancet 1998;351: 1210.
  • 43
    Durón R, Medina MT, Holden KR, et al. Pilot trial on antiepileptic treatment compliance in epileptic patients at Hospital Escuela, Tegucigalpa, Honduras, CA. Rev Med Hond 2001;69: 1405.
  • 44
    Krishnamoorthy ES, Satishchandra P, Sander JW. Research in epilepsy: development priorities for developing nations. Epilepsia 2003;44: 58.